PUBLIC POLICY
ASM Policy efforts focus on communicating the importance of the microbial science to Congress, Federal Agencies and the Public.

The American Society for Microbiology is in complete support of the National Institutes of Health lifting the funding pause on gain-of-function (GoF) experiments involving influenza, SARS, and MERS viruses. 

The ASM signed on to a letter to the director of the Office of Management and Budget encouraging the heads of all federal agencies to support the use of science in decision making and to support the scientists who produce the knowledge upon which the nation’s economy relies.

The ASM supports the Centers for Disease Control and Prevention and the importance of evidence-based science to inform policy decisions surrounding prevention and defending the country from public health threats.

The December issue of the Minority Microbiology Mentor has been published by the Committee on Microbiological Issues Impacting Minorities

Tuesday, 05 December 2017 11:25

ASM Urges Increased Funding for CDC

The ASM participated in a coalition letter urging Congress to provide at least $7.8 billion for the Centers for Disease Control and Prevention’s programs as they work to develop a final FY 2018 Labor, Health and Human Services, Education and Related Agencies Appropriations bill or other final FY 2018 funding legislation.

Monday, 27 November 2017 10:22

ASM Urges Increased Funding for AMR Programs

The ASM participated in a coalition letter urging Congress to increase funding for programs that address antimicrobial resistance (AMR) and to continue bipartisan support for AMR that reflects the US commitment to infection prevention, antimicrobial stewardship, surveillance and innovation.

ASM joins a letter to Congress opposing provisions in the Tax Cuts and Jobs Act (HR1) that will increase the financial burden for graduate students.

The ASM sent a letter to Congress as they debate H.R. 1, the Tax Cuts and Jobs Act which would exclude tuition waivers and tuition exemptions from income for graduate students. 

The ASM participated in a coalition letter urging Congress to enact a bipartisan budget agreement that raises the spending caps and enables a $36.1 billion investment in National Institutes of Health in FY 2018.

The ASM participated in  a coalition  letter urging Congress to provide emergency supplemental funding for critical public health, healthcare and behavioral health services to address the ongoing crises in Texas, Florida, Puerto Rico, and the U.S. Virgin Islands and other states impacted by Hurricanes Harvey, Irma and Maria.

The ASM signed on to a letter to President Trump regarding the Administration’s immigration policies.  The letter stressed that the signed organizations think that the policies will reduce US science and engineering output and competitiveness.

ASM joined members of the Clinical Laboratory Coalition in a letter to CMS Administrator Seema Verma asking for input on the data to be used on proposed Clinical Laboratory Fee Schedule (CLFS) rates.

The ASM suggests that ACGME recognize the contributions of ABMM certified microbiologists in the education of pathology residents by qualifying them for core faculty status.

The October issue of the Minority Microbiology Mentor Newsletter has been published by the Committee on Microbiological Issues Impacting Minorities.

The ASM joined over 50 health care organizations in a letter to Congressional Leadership asking that they ensure that all members of the health care workforce with Deferred Action for Childhood Arrivals (DACA) status are able to continue their employment, education, training, and research, with passage of a permanent legislative remedy, such as the bipartisan, bicameral Dream Act of 2017 (S. 1615, H.R. 3440).

Marc Couturier and Laura Filkins, members of the PSAB Committee on Laboratory Practices, authored a document entitled “Cyclospora Detection and Reporting from Clinical Samples” to assist our members in identifying a parasite which has been on the rise in intestinal illnesses.  Cyclospora is not usually detected by a conventional O&P examination but can be detected using modified stains, which are detailed in the document.

Effective October 14, 2016, the Centers for Disease Control and Prevention (CDC) in the Department of Health and Human Services (HSS) added great ape pathogen Bacillus cereus biovar anthracis as a Tier 1 select agent to the list of select agents and toxins.  This white paper provides information about this organism and suggests ways to identify it.

Thursday, 24 August 2017 07:52

Coalition Letter on NIH F&A Costs

The ASM joined over 100 health care and scientific organizations in a letter to OMB Director Mick Mulvaney and DHHS Secretary Tom Price opposing the Administration’s move to reduce the National Institutes of Health Facilities and Administrative (F&A) cost, also known as indirect costs, by $7.2 billion or 21 percent.  These cuts would undermine NIH biomedical research achievements and would jeopardize future progress.

The August issue of the Minority Microbiology Mentor Newsletter has been published by the Committee on Microbiological Issues Impacting Minorities.

ASM submitted comments to CMS on payment for new codes which will be included in the 2018 Medicare Clinical Laboratory Fee Schedule (CLFS). New codes considered included detection of antibiotic resistance genes and new antibody and PCR tests for Zika.

Page 1 of 5

TPL_asm2013_ADDITIONAL_INFORMATION

TPL_asm2013_SEARCH